Development of an In-Capillary Approach to Nanoscale Automated in Vitro Cytochromes P450 Assays

Journal of Medicinal Chemistry
2009.0

Abstract

A method to perform nanoscale automated CYP450-based drug metabolism studies using a capillary as a reaction vessel is described. In-capillary assays consumed only approximately 30 nL of recombinant human CYP450 solution. Ultrafast analysis of substrates and metabolites was achieved off-line by ultrahigh-pressure liquid chromatography coupled to mass spectrometry. This approach was successfully applied to qualitative metabolism studies of six major CYP450 isozymes and CYP2D6 inhibition experiments.

Knowledge Graph

Similar Paper

Development of an In-Capillary Approach to Nanoscale Automated in Vitro Cytochromes P450 Assays
Journal of Medicinal Chemistry 2009.0
Development of a cell viability assay to assess drug metabolite structure–toxicity relationships
Bioorganic & Medicinal Chemistry Letters 2016.0
In vitro metabolism of the alkaloid piplartine by rat liver microsomes
Journal of Pharmaceutical and Biomedical Analysis 2014.0
Validation of Model of Cytochrome P450 2D6:  An in Silico Tool for Predicting Metabolism and Inhibition
Journal of Medicinal Chemistry 2004.0
A Refined Cytochrome P450 IC50 Shift Assay for Reliably Identifying CYP3A Time-Dependent Inhibitors
Drug Metabolism and Disposition 2011.0
CYP2C9 Structure−Metabolism Relationships:  Substrates, Inhibitors, and Metabolites
Journal of Medicinal Chemistry 2007.0
Design and synthesis of a new fluorescent probe for cytochrome P450 3A4 (CYP 3A4)
Bioorganic & Medicinal Chemistry Letters 2003.0
Isocratic high-performance liquid chromatographic method for studying the metabolism of blood plasma pyrimidine nucleosides and bases: concentration and radioactivity measurements
Journal of Chromatography B: Biomedical Sciences and Applications 1988.0
CYP4F Enzymes Are Responsible for the Elimination of Fingolimod (FTY720), a Novel Treatment of Relapsing Multiple Sclerosis
Drug Metabolism and Disposition 2011.0
Homology modeling and molecular dynamics of CYP1A1 and CYP2B1 to explore the metabolism of aryl derivatives by docking and experimental assays
European Journal of Medicinal Chemistry 2010.0